Q/C TECHNOLOGIES, INC.
Company Information
Industry In Vitro & In Vivo Diagnostic Substances
SIC Code 2835
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
Mailing Address 1185 AVENUE OF THE AMERICAS, NEW YORK, NY, 10036
Phone 856-848-8698
Fiscal Year End 1231
EIN 000000000
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 13, 2026 | View on SEC |
| S-3 Shelf registration for future offerings | February 11, 2026 | View on SEC |
| 3 Initial insider ownership report | January 30, 2026 | View on SEC |
| 4 Insider stock transaction report | January 30, 2026 | View on SEC |
| 8-K Current report of material events | January 23, 2026 | View on SEC |
| 8-K Current report of material events | December 9, 2025 | View on SEC |
| 10-Q Quarterly financial report | November 19, 2025 | View on SEC |
| 4 Insider stock transaction report | November 18, 2025 | View on SEC |
| SCHEDULE 13D/A Beneficial ownership amendment | November 18, 2025 | View on SEC |
| 4 Insider stock transaction report | November 17, 2025 | View on SEC |
Material Events
8-K Financial Distress March 13, 2026
High Impact
- Q/C Technologies dismissed its auditor, Stephano Slack LLC, and appointed Grassi & Co., CPAs, P.C., after Stephano Slack issued "going concern" warnings for FY2023 and FY2024.
- The "going concern" warnings were due to recurring net losses and negative cash flows from operations, indicating substantial doubt about the company's viability.
Related Companies
Companies in the same industry (SIC: 2835)
IMMUCELL CORP /DE/
ICCC In Vitro & In Vivo Diagnostic Substances
Insight Molecular Diagnostics Inc.
IMDX In Vitro & In Vivo Diagnostic Substances
ACHIEVE LIFE SCIENCES, INC.
ACHV In Vitro & In Vivo Diagnostic Substances
Cardio Diagnostics Holdings, Inc.
CDIO In Vitro & In Vivo Diagnostic Substances
MYRIAD GENETICS INC
MYGN In Vitro & In Vivo Diagnostic Substances
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.